ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SPRO Spero Therapeutics Inc

1.65
0.04 (2.48%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Spero Therapeutics Inc SPRO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.04 2.48% 1.65 09:00:00
개장가 저가 고가 종가 전일 종가
1.63 1.62 1.6494 1.63 1.61
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/03/202422:05GLOBESpero Therapeutics to Provide Business Update and Report..
28/02/202422:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
26/02/202422:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
10/02/202406:05EDGAR2Form 8-K - Current report
06/02/202410:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202410:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202410:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202410:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202410:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:50EDGAR2Form 144 - Report of proposed sale of securities
01/02/202406:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
08/01/202420:07EDGAR2Form 8-K - Current report
05/01/202422:11EDGAR2Form 8-K - Current report
05/01/202422:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
05/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202422:13EDGAR2Form 8-K - Current report
02/01/202422:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
16/11/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202306:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202306:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202306:13EDGAR2Form 8-K - Current report
14/11/202306:05GLOBESpero Therapeutics Announces Third Quarter 2023 Operating..
14/11/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202320:45IHMARKETNEWSMonday’s Wall Street Highlights: Boeing, Novo Nordisk,..
06/11/202322:05GLOBESpero Therapeutics to Provide Business Update and Report..
02/11/202305:05GLOBESpero Therapeutics to Present at Upcoming November Investor..
01/11/202321:10EDGAR2Form 8-K - Current report
01/11/202321:05GLOBESpero Therapeutics Appoints Esther Rajavelu as Chief..
01/11/202305:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
17/10/202305:01EDGAR2Form 8-K/A - Current report: [Amend]
11/10/202306:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202321:28EDGAR2Form 8-K - Current report
30/09/202305:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
21/09/202305:05GLOBESpero Therapeutics to Present at Cantor’s Global Healthcare..
16/09/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202321:05GLOBESpero Therapeutics to Present at H.C. Wainwright 25th Annual..
02/09/202305:11EDGAR2Form ARS - Annual Report to Security Holders
02/09/202305:08EDGAR2Form DEF 14A - Other definitive proxy statements
01/09/202305:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
31/08/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:16EDGAR2Form 144 - Report of proposed sale of securities
23/08/202306:27EDGAR2Form PRE 14A - Other preliminary proxy statements
11/08/202305:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/08/202305:17EDGAR2Form 8-K - Current report
11/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:05GLOBESpero Therapeutics Announces Second Quarter 2023 Operating..

최근 히스토리

Delayed Upgrade Clock